Pal Pacher

Dikutip oleh

	Semua	Sejak 2020
Kutipan	68241	22526
indeks-h	137	76
indeks-i10	363	291

5000

2500

1250

3750

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025208 365 558 931 1030 1690 2369 2685 2600 2918 3249 3263 3562 3503 3880 3850 3989 4034 4512 4946 4506 3944 3793 816

Akses publik

Lihat semua

215 artikel

12 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

george haskoColumbia UniversityEmail yang diverifikasi di cumc.columbia.edu
Partha Mukhopadhyay, MS, Ph.D.National Institutes of HealthEmail yang diverifikasi di mail.nih.gov
Sandor Batkai MD, PhDCardior Pharmaceutical GmbHEmail yang diverifikasi di cardior.de
Csaba SzaboProfessor, Chair of Pharmacology, University of Fribourg, SwitzerlandEmail yang diverifikasi di unifr.ch
Jon MableyUniversity of BrightonEmail yang diverifikasi di brighton.ac.uk
George KunosScientific Director, NIAAA/NIHEmail yang diverifikasi di nih.gov
Rajesh MohanrajAssistant Professor, Department of Pharmacology and Therapeutics, UAE universityEmail yang diverifikasi di uaeu.ac.ae
Zoltan Ungvari, M.D., Ph.D.Vascular Cognitive Impairment & Neurodegeneration Program OUHSCEmail yang diverifikasi di ouhsc.edu
Bin GaoChief, Laboratory of Liver Diseases, NIAAA, NIHEmail yang diverifikasi di mail.nih.gov
Balazs CsokaCelgeneEmail yang diverifikasi di celgene.com
Németh ZoltánEmail yang diverifikasi di ladypower.hu
Zoltan VargaSemmelweis University, HCEMMEmail yang diverifikasi di med.semmelweis-univ.hu
Francisco Garcia SorianoProfessor Associado, Departamento de Clínica Médica da Faculdade de Medicina da Universidade de SãoEmail yang diverifikasi di usp.br
Katalin Erdelyipost doctoral fellowEmail yang diverifikasi di mail.nih.gov
Janos PalocziLSU Health Science CenterEmail yang diverifikasi di lsuhsc.edu
Laszlo ViragProfessor of Medical Chemistry, University of Debrecen, Faculty of Medicine, HungaryEmail yang diverifikasi di med.unideb.hu
Luca AntonioliDept Clinical and Experimental Medicine University of PisaEmail yang diverifikasi di medmcs.unipi.it
E. Sylvester Vizi MD, PhD, MHAS, Ho...Hun-Ren Inst. of Experimental Medicine, and Semmelweis University, Department of Pharmacology andEmail yang diverifikasi di koki.hu
Ken MackieProfessor Psychological and Brain Sciences, Indiana UniversityEmail yang diverifikasi di indiana.edu
Douglas Osei-HyiamanNational Institutes of HealthEmail yang diverifikasi di mail.nih.gov

Ikuti

Pal Pacher

National Institutes of Health, Bethesda

Email yang diverifikasi di mail.nih.gov - Beranda

drug discovery pharmacology cardiovascular disease GPCRs oxidative stress


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Nitric oxide and peroxynitrite in health and disease P Pacher, JS Beckman, L Liaudet Physiological reviews 87 (1), 315-424, 2007	7907	2007
The endocannabinoid system as an emerging target of pharmacotherapy P Pacher, S Bátkai, G Kunos Pharmacological reviews 58 (3), 389-462, 2006	2757	2006
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol PAL Pacher, A Nivorozhkin, C Szabó Pharmacological reviews 58 (1), 87-114, 2006	1581	2006
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases G Haskó, J Linden, B Cronstein, P Pacher Nature reviews Drug discovery 7 (9), 759-770, 2008	1441	2008
Endocannabinoid activation at hepatic CB₁ receptors stimulates fatty acid synthesis and contributes to diet-induced obesity D Osei-Hyiaman, M DePetrillo, P Pacher, J Liu, S Radaeva, S Bátkai, ... The Journal of clinical investigation 115 (5), 1298-1305, 2005	1382	2005
CD39 and CD73 in immunity and inflammation L Antonioli, P Pacher, ES Vizi, G Haskó Trends in molecular medicine 19 (6), 355-367, 2013	1356	2013
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential OV Evgenov, P Pacher, PM Schmidt, G Haskó, HHHW Schmidt, JP Stasch Nature reviews Drug discovery 5 (9), 755-768, 2006	931	2006
Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats P Pacher, T Nagayama, P Mukhopadhyay, S Bátkai, DA Kass Nature protocols 3 (9), 1422-1434, 2008	865	2008
Activation of the peripheral endocannabinoid system in human obesity S Engeli, J Bohnke, M Feldpausch, K Gorzelniak, J Janke, S Bátkai, ... Diabetes 54 (10), 2838-2843, 2005	853	2005
Immunity, inflammation and cancer: a leading role for adenosine L Antonioli, C Blandizzi, P Pacher, G Haskó Nature Reviews Cancer 13 (12), 842-857, 2013	846	2013
Endocannabinoid signaling at the periphery: 50 years after THC M Maccarrone, I Bab, T Bíró, GA Cabral, SK Dey, V Di Marzo, JC Konje, ... Trends in pharmacological sciences 36 (5), 277-296, 2015	784	2015
Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease JP Stasch, P Pacher, OV Evgenov Circulation 123 (20), 2263-2273, 2011	689	2011
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors N Agarwal, P Pacher, I Tegeder, F Amaya, CE Constantin, GJ Brenner, ... Nature neuroscience 10 (7), 870-879, 2007	668	2007
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity M Bluher, S Engeli, N Kloting, J Berndt, M Fasshauer, S Bátkai, P Pacher, ... Diabetes 55 (11), 3053-3060, 2006	654	2006
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? P Pacher, V Kecskemeti Current pharmaceutical design 10 (20), 2463-2475, 2004	605	2004
Is lipid signaling through cannabinoid 2 receptors part of a protective system? P Pacher, R Mechoulam Progress in lipid research 50 (2), 193-211, 2011	563	2011
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy M Rajesh, P Mukhopadhyay, S Bátkai, V Patel, K Saito, S Matsumoto, ... Journal of the American College of Cardiology 56 (25), 2115-2125, 2010	550	2010
Drug-induced mitochondrial dysfunction and cardiotoxicity ZV Varga, P Ferdinandy, L Liaudet, P Pacher American Journal of Physiology-Heart and Circulatory Physiology 309 (9 …, 2015	546	2015
Evidence for novel cannabinoid receptors M Begg, P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, FM Mo, J Liu, ... Pharmacology & therapeutics 106 (2), 133-145, 2005	534	2005
Resveratrol induces mitochondrial biogenesis in endothelial cells A Csiszar, N Labinskyy, JT Pinto, P Ballabh, H Zhang, G Losonczy, ... American Journal of Physiology-Heart and Circulatory Physiology 297 (1), H13-H20, 2009	502	2009

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama